In response to a petition filed by the Indian Medical Association (IMA), the court has instructed Patanjali to refrain from making any deceptive statements and has threatened significant penalties for non-compliance.
“All false and misleading advertisements by Patanjali Ayurved have to stop immediately. This Court will take such infractions very seriously and will consider imposing costs of up to Rs 1 crore on every product for which a false claim is made that it can cure a particular disease,” Justice Amanullah remarked.
In addition to addressing Patanjali’s advertising practices, the Supreme Court has urged the Union to present a proposal aimed at tackling misleading medical advertisements more broadly. The move comes in response to concerns raised by the IMA regarding Patanjali’s campaigns that seemingly criticized modern medicine and vaccination efforts.
The Supreme Court’s intervention underscores the gravity of the issue, emphasizing the need for responsible advertising in the medical field. The outcome of this legal development could have implications not only for Patanjali but also for the broader landscape of medical advertising in India, prompting a reevaluation of regulations and standards to ensure accurate and transparent communication in the healthcare sector.
source by: Money Control News
Read the latest and breaking Hindi news | English News on अब पाएं सबसे निष्पक्ष, विश्वसनीय और तेज खबरें, सिर्फ WWW.THEINSIGHTTODAY.COM पर।. Get live Hindi news about India and the World from politics, sports, bollywood, business, cities, lifestyle, astrology, spirituality, jobs and much more..
Read Latest News on your Mobile app so Download Mobile app The Insight Today